Literature DB >> 24846081

Apparent diffusion coefficient value of hepatic fibrosis and inflammation in children with chronic hepatitis.

Ahmed Abdel Khalek Abdel Razek1, Mohamed Khashaba2, Ahmed Abdalla2, Mohamed Bayomy2, Tarek Barakat2.   

Abstract

PURPOSE: This study was done to prospectively evaluate the usefulness of apparent diffusion coefficient (ADC) in the diagnosis and grading of hepatic fibrosis and inflammation in children with chronic hepatitis.
MATERIALS AND METHODS: Institutional Review Board approval was obtained. This prospective study was carried out on 50 children with chronic hepatitis (mean age 8.3 ± 3.2 years; 33 boys and 17 girls) and 20 age- and sex-matched healthy control children. The children underwent diffusion-weighted magnetic resonance imaging of the liver. The ADC value of the liver was calculated. The hepatic fibrosis stages (F1-F6) and necroinflammatory activity grades (A1-A4) were calculated. The ADC values of different stages of hepatic fibrosis and grades of necroinflammatory activity were calculated.
RESULTS: The mean ADC value of the liver parenchyma was 1.53 ± 0.17 × 10(-3) mm(2)/s in children with chronic hepatitis and 1.74 ± 0.16 × 10(-3) mm(2)/s in controls. The ADC value was significantly lower in children with hepatic fibrosis compared to controls (p = 0.001). There was a significant difference (p = 0.001) in ADC between mild (F1-F3) and advanced (F4-F6) stages of fibrosis. There was a significant difference (p = 0.004) in ADC between mild (A1-A2) and advanced (A3-A4) grades of necroinflammation. The cut-off ADC values used to differentiate mild from advanced fibrosis and necroinflammation were 1.62 and 1.64 mm(2)/s with an area under the curve of 0.898 and 0.807, respectively. The ADC value negatively correlated with stages of hepatic fibrosis (r = -0.799, p = 0.001) and necroinflammatory activity grade (r = -0.468, p = 0.001).
CONCLUSIONS: We conclude that ADC value is an effective noninvasive parameter for the diagnosis and grading of hepatic fibrosis and inflammation in children with chronic hepatitis.

Entities:  

Mesh:

Year:  2014        PMID: 24846081     DOI: 10.1007/s11547-014-0408-x

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  47 in total

1.  Diffusion-weighted MRI versus transient elastography in quantification of liver fibrosis in patients with chronic cholestatic liver diseases.

Authors:  Jelena Djokić Kovač; Marko Daković; Dejana Stanisavljević; Tamara Alempijević; Rada Ješić; Petar Seferović; Ružica Maksimović
Journal:  Eur J Radiol       Date:  2011-11-17       Impact factor: 3.528

2.  Utility of diffusion-weighted imaging in the evaluation of liver fibrosis.

Authors:  Ayse Ahsen Bakan; Ercan Inci; Selim Bakan; Suut Gokturk; Tan Cimilli
Journal:  Eur Radiol       Date:  2011-10-09       Impact factor: 5.315

3.  Differentiation between benign and malignant orbital tumors at 3-T diffusion MR-imaging.

Authors:  Ahmed Abdel Khalek Abdel Razek; Sahar Elkhamary; Amani Mousa
Journal:  Neuroradiology       Date:  2011-02-01       Impact factor: 2.804

4.  Non-invasive assessment of liver fibrosis using ARFI with pathological correlation, a prospective study.

Authors:  Wan Wan Yap; Rathy Kirke; Eric M Yoshida; David Owen; Alison C Harris
Journal:  Ann Hepatol       Date:  2013 Jul-Aug       Impact factor: 2.400

5.  Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade.

Authors:  Kiminori Fujimoto; Tatsuyuki Tonan; Sanae Azuma; Masayoshi Kage; Osamu Nakashima; Takeshi Johkoh; Naofumi Hayabuchi; Koji Okuda; Takumi Kawaguchi; Michio Sata; Aliya Qayyum
Journal:  Radiology       Date:  2011-01-19       Impact factor: 11.105

6.  Non-invasive assessment of liver fibrosis: the gap between ideal and real.

Authors:  Seung Up Kim; Kwang-Hyub Han; Sang Hoon Ahn
Journal:  J Gastroenterol Hepatol       Date:  2011-06       Impact factor: 4.029

7.  Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging.

Authors:  Diego A Aguirre; Cynthia A Behling; Elliot Alpert; Tarek I Hassanein; Claude B Sirlin
Journal:  Radiology       Date:  2006-05       Impact factor: 11.105

8.  Idiopathic Parkinson disease effect of levodopa on apparent diffusion coefficient value of the brain.

Authors:  Ahmed Abdel Khalek Abdel Razek; Azza Elmongy; Maha Hazem; Shirin Zakareyia; Wael Gabr
Journal:  Acad Radiol       Date:  2011-01       Impact factor: 3.173

9.  Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.

Authors:  Haruo Watanabe; Masayuki Kanematsu; Satoshi Goshima; Hiroshi Kondo; Minoru Onozuka; Noriyuki Moriyama; Kyongtae T Bae
Journal:  Radiology       Date:  2011-01-19       Impact factor: 11.105

10.  Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation.

Authors:  Mesude Tosun; Nagihan Inan; Hasan Tahsin Sarisoy; Gur Akansel; Sevtap Gumustas; Yeşim Gürbüz; Ali Demirci
Journal:  Eur J Radiol       Date:  2012-11-02       Impact factor: 3.528

View more
  17 in total

1.  Comparison of diffusion-weighted imaging and MR elastography in staging liver fibrosis: a meta-analysis.

Authors:  Weon Jang; Seongil Jo; Ji Soo Song; Hong Pil Hwang; Seong-Hun Kim
Journal:  Abdom Radiol (NY)       Date:  2021-03-26

2.  Diffusion tensor imaging of the spleen in prediction and grading of esophageal varices in cirrhotic children with portal hypertension.

Authors:  Ahmed Abdel Khalek Abdel Razek; Mona Mohamed Hafez; Walaa Mahmoud; Ahmed Ramadan Ismail; Khadiga M Ali; Tarek Elsayed Barakat
Journal:  Jpn J Radiol       Date:  2021-04-29       Impact factor: 2.374

3.  Liver histology and diffusion-weighted MRI in children with nonalcoholic fatty liver disease: A MAGNET study.

Authors:  Paul Manning; Paul Murphy; Kang Wang; Jonathan Hooker; Tanya Wolfson; Michael S Middleton; Kimberly P Newton; Cynthia Behling; Hannah I Awai; Janis Durelle; Melissa N Paiz; Jorge E Angeles; Diana De La Pena; J Allen McCutchan; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2017-02-22       Impact factor: 4.813

Review 4.  Advances in diffusion-weighted imaging.

Authors:  Lorenzo Mannelli; Stephanie Nougaret; Hebert A Vargas; Richard K G Do
Journal:  Radiol Clin North Am       Date:  2015-05       Impact factor: 2.303

5.  Diffusion tensor imaging of renal cortex in lupus nephritis.

Authors:  Ahmed Abdel Khalek Abdel Razek; Ahmed Mohamed Abdel Khalek; Samar Tharwat; Mohammed Kamal Nassar; Nihal Tharwat
Journal:  Jpn J Radiol       Date:  2021-06-14       Impact factor: 2.374

6.  Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study.

Authors:  N E El-Ashmawy; E A El-Zamarany; E G Khedr; H A El-Bahrawy; O A El-Feky
Journal:  Clin Transl Oncol       Date:  2018-10-27       Impact factor: 3.405

7.  Detecting serum and urine metabolic profile changes of CCl4-liver fibrosis in rats at 12 weeks based on gas chromatography-mass spectrometry.

Authors:  Jiarong Gao; Xiu-Juan Qin; Hui Jiang; Jin-Feng Chen; Ting Wang; Ting Zhang; Shuang-Zhi Xu; Jun-Mei Song
Journal:  Exp Ther Med       Date:  2017-06-26       Impact factor: 2.447

8.  Computed Tomography Assessment of Hepatic Metastases of Breast Cancer with Revised Response Evaluation Criteria in Solid Tumors (RECIST) Criteria (Version 1.1): Inter-Observer Agreement.

Authors:  Fady Emil Ibrahim Ghobrial; Manal Salah Eldin; Ahmed Abdel Khalek Abdel Razek; Nadia Ibrahim Atwan; Sameh Sayed Ahmed Shamaa
Journal:  Pol J Radiol       Date:  2017-10-20

9.  Celecoxib attenuates hepatocyte apoptosis by inhibiting endoplasmic reticulum stress in thioacetamide-induced cirrhotic rats.

Authors:  Wei Su; Yang Tai; Shi-Hang Tang; Yan-Ting Ye; Chong Zhao; Jin-Hang Gao; Bi-Guang Tuo; Cheng-Wei Tang
Journal:  World J Gastroenterol       Date:  2020-07-28       Impact factor: 5.742

10.  The correlation between controlled attenuation parameter and metabolic syndrome and its components in middle-aged and elderly nonalcoholic fatty liver disease patients.

Authors:  Yue-Yan Hu; Ning-Ling Dong; Qiu Qu; Xu-Fan Zhao; Hong-Ju Yang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.